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Introduction
The genus Xanthium (Asteraceae,  Heliantheae), 
represented by 25 species, exhibits a global distri-
bution and is found abundantly throughout Eura-
sia and America. This genus has been the subject 
of many chemical studies, which have led to the 
isolation of a special type of sesquiterpene lac-
tones (xanthanolides) (Saxena and Mondal, 1994), 
diterpenes (Piacente et al., 1996), thiazinediones 
(Ma et al., 1998; Qin et al., 2006), sterols and caffe-
oylquinic acids (Agata et al., 1993) as main sec-
ondary metabolites. Xanthium species have been 
used in traditional herbal medicine worldwide; 
some of them have been applied for the treat-
ment of basal cell carcinoma, different cancers 
and “cold tumours” (Hartwell, 1968). X. italicum 
Moretti [syn. X. strumarium L. subsp. italicum 
(Moretti) D. Löve], a member of the X. strumar-
ium group, has been used in folk medicine against 
cancers in Latin-America (Hartwell, 1968). Previ-
ous investigations revealed the presence of xanth-
anolides and phytosterols in X. italicum (Marco et 
al., 1993; Tsankova et al., 1993, 1994).
In the course of our screening programme for 
antiproliferative compounds in Central and East-
ern European Asteraceae species, extracts of X. 
italicum were investigated earlier (Réthy et al., 
2007). High tumour cell growth inhibitory activi-
ties on HeLa (cervix adenocarcinoma), A431 (skin 
carcinoma), and MCF7 (breast adenocarcinoma) 
human cell lines were recorded in vitro for differ-
ent lipophilic extracts by means of the MTT assay. 
The present paper reports on investigations of the 
antiproliferative effects of the extracts of differ-
ent plant parts of X. italicum, collected before and 
in the fl owering stage, with the aim of selecting 
the most effective extract. The bioassay-guided 
fractionation of the CHCl3 extract of the leaves 
was additionally performed in an effort to identi-
fy the compounds responsible for the tumour cell 
growth inhibitory effect. This led to the isolation 
and identifi cation of four xanthanolides: xantha-
tin (1), 4-epixanthanol (2), 4-epi-isoxanthanol (3), 
and 2-hydroxyxanthinosin (4), all possessing tu-
mour cell growth inhibitory activities.
Results and Discussion
The dried and powdered plant parts (radix, 
fl ower, stem and leaf) collected before and during 
the fl owering period were extracted with MeOH 
and, after evaporation, the residues from the ex-
tracts were subjected to solvent-solvent partition-
ing. Extraction with lipophilic solvents yielded n-
hexane-, CHCl3- and H2O-soluble phases. These 
fractions, together with the original MeOH ex-
tract, were tested for their tumour cell prolifera-
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tion inhibitory activities on the HeLa, A431 and 
MCF7 cell lines (Fig. 1). It was observed that the 
main active components proved to be accumu-
lated in the leaves and fl owers, especially in the 
n-hexane and CHCl3 extracts. The extracts from 
the stems exerted only low effects (< 53%) on all 
three cell lines. The extracts from the roots in the 
fl owering stage were more active than those from 
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Fig. 1. Antiproliferative activities of extracts from different parts of X. italicum on human tumour cell lines (1, 
MeOH extract; 2, n-hexane fraction; 3, CHCl3 fraction; 4, H2O fraction) at a concentration of 10 µg/ml. b.f., Before 
fl owering; d.f., during fl owering.
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before the fl owering period. The fractions with dif-
ferent polarities revealed that the CHCl3 extracts 
exerted the highest activity, with exception of the 
root during the fl owering period, where the active 
compounds accumulated in the n-hexane extracts. 
The CHCl3 extract of the leaves exhibited marked 
cell growth inhibitory activities of 102.0, 88.5 and 
99.1% on the HeLa, MCF7 and A431 cells, respec-
tively, and this extract was therefore selected for a 
detailed study. In order to identify the active com-
ponents, the CHCl3 extract was fi rst separated by 
column chromatography into fi ve main fractions. 
Of these fractions I and IV (at 10 μg/ml) exhibited 
cell growth inhibitory activities of 85.0 and 97.2% 
on the HeLa, 101.2 and 88.2% on the A431, and 
93.2 and 86.3% on the MCF7 cell line. Fraction I 
was subjected to multiple chromatographic purifi -
cations, including vacuum liquid chromatography 
(VLC), centrifugal planar chromatography (CPC) 
and HPLC, which afforded compounds 1 – 4.
Compound 1 was obtained as white crystals, 
and identifi ed as xanthatin by comparison of its 
13C NMR spectral data with those published by 
Marco et al. (1993). The detailed NMR studies, in-
cluding 1H NMR, JMOD, 1H-1H COSY, NOESY, 
HSQC and HMBC experiments, resulted in 
complete 1H chemical shift assignments for 1, as 
listed in the experimental section. The NOESY 
experiment provided information on the stere-
ochemistry of the chiral centres (C-7, C-8 and 
C-10). The Overhauser effects detected between 
H-8/H-14, H-8/H-6β and H-9β/H-8, and between 
H-6α/H-7 and H-7/H-9α proved the trans lactone 
ring junction and the β-oriented 14-methyl group. 
Xanthatin (1), Fig. 2, which was obtained in the 
highest yield, is one of the main xanthanolides: 
it has been isolated previously from X. italicum 
(Tsankova et al., 1994), X. macrocarpum (Lavault 
et al., 2005), X. spinosum (Omar et al., 1984), X. 
sibiricum (Sato et al., 1997), and X. strumarium 
(McMillan et al., 1975). This compound has at-
tracted considerable attention because of its an-
tileishmanial, antifungal (Lavault et al., 2005), and 
nitric oxide synthesis and COX-2 inhibitory ac-
tivities (Yoon et al., 2008).
Compounds 2 and 3 were isolated as colour-
less oils. On the basis of their 1H and 13C NMR 
data, they were identifi ed as 4-epixanthanol (2) 
and 4-epi-isoxanthanol (3) (Marco et al., 1993) 
(Fig. 2).
Compound 4 was isolated as a colourless gum. 
Its 1H NMR and JMOD spectra (Table I) revealed 
the presence of a methylene-substituted lactone 
ring (δH 6.16 d, 5.45 d, 4.30 dt, 2.44 m; δC 169.5, 
139.4, 118.5, 82.2, 48.2 ppm), and contained signals 
for a lactone ring condensed with a methyl-substi-
tuted seven-membered ring [δH 5.86 dd, 2.55 ddd, 
2.11 ddd, 2.44 m, 4.30 dt, 2.32 dt, 1.69 dt, 2.81 m], 
characteristic of a xanthanolide. Additionally, a 
four carbon atoms containing side chain was sug-
gested by the signals at δH 4.50 dd, 2.73 dd, 2.60 dd 
and 2.21 s, and δC 209.1, 73.9, 48.7 and 30.9 ppm. 
The HSQC and 1H-1H COSY spectra led to the 
identifi cation of two methyl, fi ve methine, and four 
methylene groups and four quaternary carbon 
atoms in the molecule. The HMBC correlations 
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Fig. 3. Diagnostic NOESY correlations of 4.
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of C-1 with H-2, H-3 and H-5, of C-4 with H-2, 
H-3 and H-15, and of C-2 with H-3, H-5 and H-10 
proved the 2-hydroxy-4-oxo-1(5)-ene-substituted 
xanthanolide structure. The stereochemistry of 
4 was investigated by NOESY experiments. The 
Overhauser effects between H-7/H-9α, H-10/H-2, 
H-5/H-2 and H-5/H-6α indicated protons below 
the plane of the molecule, while the NOE interac-
tions between H-8/H-9β, H-8/H-6β and H-8/H-14 
demonstrated β-oriented H-8 and H-14 (Fig. 3). 
All of the above data supported the structure of 
2-hydroxyxanthinosin for 4 (Fig. 2), with the fi rst 
stereochemical characterization of C-2, and deter-
mination of the complete 13C NMR assignments 
as listed in Table I.
The isolated xanthanolides were tested against 
the HeLa, MCF7 and A431 cell lines, and all were 
found to exert signifi cant cell growth inhibitory 
effects (Table II). Compound 1 demonstrated the 
highest activity with IC50 values of 8.00, 3.44 and 
5.19 µM on the HeLa, A431 and MCF7 cell lines, 
respectively; its potency was close to that of the 
positive control, cisplatin. 2-Hydroxyxanthinosin 
(4) displayed signifi cant activity (IC50 7.78 µM) 
against HeLa cells, and 2 and 3 exerted moder-
ate effects (IC50 15.53−37.62 µM) against all three 
tumour cell lines.
Compounds 1 – 4 contain an α-methylene-γ-
lactone ring, which is generally regarded as a 
structural requirement of sesquiterpenes for cy-
totoxic activity. The most potent, xanthatin (1), 
has an additional α,β-unsaturated carbonyl group 
in the side chain; this structural feature presum-
ably enhances the antitumour activity. In previ-
ous pharmacological studies, this side chain was 
similarly found to be responsible for pronounced 
Table I. NMR spectral data of 2-hydroxyxanthinosin (4) [500 MHz (1H), 125 MHz (13C), CDCl3, TMS, δ (ppm) (J 
in Hz)].
Position 1H 13C HMBC (C→H) NOESY
1 – 148.3 H-2, H-3a, H-3b, H-5, H-6α, H-6β, 
H-9α, H-9β, H-10, H-14
–
2 4.50 dd (9.3, 1.4) 73.9 H-3a, H-3b, H-5, H-10 H-3b, H-5, H-10
3a 2.73 dd (17.2, 9.6) 48.7 H-15 H-2, H-3b, H-10, H-14
3b 2.60 dd (17.2, 2.7) H-3a
4 – 209.1 H-2, H-3a, H-3b, H-15 –
5 5.86 dd (9.2, 3.2) 123.7 H-2, H-6α, H-6β, H-10 H-2, H-6α
6α 2.55 ddd (15.1, 9.2, 2.2) 25.2 H-5, H-8 H-5, H-6β, H-7, H-13b
6β 2.11 ddd (15.1, 12.0, 3.2) H-6α, H-7, H-8, H-14
7 2.44 m 48.2 H-6α, H-6β, H-9α, H-9β, H-13a, H-13b H-6α, H-6β, H-9α
8 4.30 dt (12.5, 2.8) 82.2 H-6β, H-9α, H-9β H-6β, H-9β, H-14
9β 2.32 dt (13.1, 3.7) 36.9 H-10, H-14 H-8, H-9α, H-10, H-14
9α 1.69 dt (12.4, 3.4) H-7, H-9β, H-10
10 2.81 m 29.7 H-2, H-5, H-8, H-9α, H-9β, H-14 H-2, H-3a, H-9β, H-9α, H-14
11 – 139.4 H-6α, H-13a, H-13b –
12 – 169.5 H-13a, H-13b –
13a 6.16 d (3.2) 118.5 H-13b
13b 5.45 d (3.2) H-6α, H-13a
14 1.17 d (7.4) 19.3 H-5, H-9α, H-9β, H-10 H-6β, H-8, H-9β, H-10
15 2.21 s 30.9 H-3a, H-3b
Table II. Antiproliferative activities (IC50 in µM) of xanthanolides 1 – 4 on HeLa, A431 and MCF7 cell lines.
Compound IC50 [μM]
HeLa A431 MCF7
Xanthatin (1)  8.00 ± 0.27  3.44 ± 0.27  5.19 ± 2.16
4-Epixanthanol (2) 15.53 ± 1.46 20.85 ± 0.66 26.81 ± 3.42
4-Epi-isoxanthanol (3) 29.83 ± 2.21 37.62 ± 2.09 17.65 ± 1.37
2-Hydroxyxanthinosin (4)  7.78 ± 1.21 97.84 ± 4.12 27.94 ± 1.44
Doxorubicin  0.15 ± 0.03  0.15 ± 0.04  0.28 ± 0.01
Cisplatin 12.43 ± 1.05  2.84 ± 0.61  9.63 ± 0.75
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biological activities, e.g. iNOS and COX-2 expres-
sion suppressive effects (Yoon et al., 2008).
In conclusion, the strong inhibitory effect of 
the leaves of X. italicum on the proliferation of 
cultured human tumour cell lines (HeLa, MCF7 
and A431) may be attributed to xanthanolides. 
Predominantly the content of the most active 
main compound, xanthatin (1), determines the 
anti tumour activity of the extracts, with the mi-
nor xanthanolides playing additional roles in this 
effect.
Material and Methods
General experimental procedures
The melting point is uncorrected. NMR spec-
tra were recorded in CDCl3 on a Bruker Avance 
DRX 500 spectrometer (500 MHz for 1H and 
125 MHz for 13C); the signals of the deuterated 
solvent were taken as the reference (7.26 ppm in 
1H NMR, and 77.0 ppm in JMOD). Two-dimen-
sional experiments (1H-1H COSY, HSQC, HMBC 
and NOESY) were set up, performed and proc-
essed with the standard Bruker protocol. For VLC, 
silica gel (Kieselgel GF254, 15 μm, Merck) was 
used. Preparative TLC was carried out on silica 
gel (Kieselgel 60F254, Merck). The chromatograms 
were visualized under UV light at 254 nm, and by 
spraying with concentrated vanillin/sulfuric acid, 
followed by heating at 110 °C for 10 min. CPC 
was carried out on a Chromatotron (Harrison 
Research Inc., Palo Alto, CA, USA) apparatus, 
using manually coated silica gel (60 GF254, Merck) 
plates with 2 or 4 mm thickness. For column chro-
matography, polyamide (ICN Polyamide 6, Ger-
many, mean particle size 50 − 160 µm) was used. 
RP-HPLC was carried out on a LiChrospher 100 
RP-18 (10 µm, 250 × 4 mm) reversed-phase (RP) 
column (Merck), and NP-HPLC on LiChrospher 
Si 100 (5 µm, 250 × 4 mm), using a Waters instru-
ment: Pump 600E, Dual λ Absorbance Detector 
2487, Injector Rheodyne 7725i, with detection at 
254 and 280 nm.
Plant material
Plant materials were collected in August 2006 
in Budaörs and in September 2006 on the banks 
of the River Tisza in Szentes, Hungary, and iden-
tifi ed by Dr. Anikó Böszörményi (Department of 
Plant Biology, University of Szeged, Hungary). 
Voucher specimens (765 and 766) are deposited 
in the herbarium of the Department of Pharma-
cognosy, University of Szeged, Hungary. The plant 
materials were dried at room temperature, yield-
ing 1070 g of aerial parts and 310 g of roots from 
the fi rst gathering, and 1020 g of leaves, 680 g of 
roots, 150 g of fl owers and 870 g of stems from the 
second gathering.
Preparation of the extract for antiproliferative 
screening
10 g of the dried and powdered plant parts (ra-
dix, fl ower, leaves, and stem) were extracted with 
3 × 100 ml MeOH. The extracts were concentrat-
ed in vacuo, and then subjected to liquid-liquid 
partition with n-hexane (3 × 50 ml) and CHCl3 
(3 × 50 ml). The fractions were concentrated and 
tested for antiproliferative activity.
Isolation of the compounds
The dried leaves (1010 g) of the plant were 
crushed and percolated with 10 l MeOH at room 
temperature. The MeOH extract was concentrat-
ed to 500 ml; then 500 ml H2O were added. The 
extract was subjected to solvent-solvent parti-
tion using 5 × 1000 ml n-hexane and 5 × 1000 ml 
CHCl3. The CHCl3 fraction (31.32 g) was chroma-
tographed on a polyamide column with mixtures 
of MeOH/H2O (1:4, 2:3, 3:2, and 4:1). A total of 50 
fractions were collected and combined on the ba-
sis of TLC monitoring, affording 5 main fractions 
(I–V). Sesquiterpenes were detected in fraction 
I. Upon standing, fraction I afforded a consider-
able amount of a crystalline material, which was 
recrystallized from MeOH to yield compound 
1 (1.12 g). The mother liquor that remained 
(10.22 g) was subjected to VLC on silica gel, using 
a gradient system of n-hexane/acetone (9:1, 4:1, 
7:3, and 1:1, 100 ml each) and CHCl3/MeOH (9:1, 
7:3, and 1:1, 100 ml each). This separation resulted 
in 11 sub-fractions, I/1 − I/11, which were tested on 
the HeLa, MCF7 and A431 cell lines. Fractions I/4 
and I/5 exhibited signifi cant activity, and were fur-
ther purifi ed. Fraction I/4 (3.39 g), obtained with 
n-hexane/acetone (7:3), was subjected repeatedly 
to silica gel VLC, using toluene/EtOAc mixtures 
of increasing polarity. From fraction I/4.1, 60.3 mg 
of 2 was crystallized. The remaining part of this 
fraction was fractionated fi rst by CPC, using a 
gradient system of toluene/EtOAc (9:1, 4:1, 7:3, 
3:2, and 1:1), and then purifi ed by NP-HPLC, us-
ing cyclohexane/EtOAc/EtOH (20:10:1) as mobile 
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phase (fl ow rate 1 ml/min), affording 3 (42 mg). 
Fraction I/5 (1.7 g), obtained with n-hexane/ac-
etone (1:1), was further purifi ed by RPC on silica 
gel, using a gradient system of toluene/EtOAc. 
Selected fractions from this chromatography 
were subjected to RP-HPLC, using MeOH/H2O 
(3:2) (fl ow rate 1 ml/min), to yield compound 4 
(10.8 mg) (tR = 3.36 min).
Xanthatin (1): White crystals; m.p. 114−115 °C. 
− 1H NMR (CDCl3, 500 MHz): δ = 7.03 (1H, d, 
J = 15.2 Hz, H-2), 6.17 (1H, d, J = 15.2 Hz, H-3), 
6.26 (1H, dd, J = 9.1, 3.3 Hz, H-5), 2.77 (1H, ddd, 
J = 16.7, 9.1, 2.6 Hz, H-6α), 2.20 (1H, ddd, J = 16.7, 
12.2, 3.3 Hz, H-6β), 2.52 (1H, dt, J = 12.2, 2.6 Hz, 
H-7), 4.26 (1H, dt, J = 12.2, 2.6, H-8), 2.34 (1H, 
ddd, J = 12.8, 3.8, 2.6 Hz, H-9β), 1.82 (1H, dt, J = 
12.8, 3.8 Hz, H-9α), 3.04 (1H, m, H-10), 6.15 (1H, 
d, J = 3.3 Hz, H-13a), 5.46 (1H, d, J = 3.3 Hz, H-
13b), 1.12 (3H, d, J = 7.5 Hz, H-14), 2.26 (3H, s, 
H-15). − 13C NMR (CDCl3, 125 MHz): data identi-
cal with those published by Marco et al. (1993).
4-Epixanthanol (2): Colourless oil. – [α]D –60° 
(c 3). − 1H and 13C NMR: data identical with those 
published by Marco et al. (1993).
4-Epi-isoxanthanol (3): Colourless oil. – [α]D 
–20° (c 1). − 1H and 13C NMR: data identical with 
those published by Marco et al. (1993).
2-Hydroxyxanthinosin (4): Colourless gum. − 
1H and 13C NMR, HMBC and NOESY data: see 
Table I.
Bioassays
Cytotoxic effects were measured in vitro on 
the HeLa (human cervix adenocarcinoma), A431 
(skin carcinoma), and MCF7 (breast adenocarci-
noma) cell lines, using the MTT [3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] 
colorimetric assay. A limited amount of human 
cancer cells (5000/well) were seeded onto a 96-
well microplate, and allowed to adhere overnight 
before the drugs were introduced. The original 
medium was then removed, 200 μl culture me-
dium containing the compound of interest were 
added, and the cells were incubated for 72 h. 
The tested extracts and compounds were dis-
solved in DMSO. The fi nal content of DMSO 
never exceeded 0.3%, and therefore had no es-
sential effect on the cell growth. Next the living 
cells were assayed: aliquots (20 μl at 5 mg/ml) of 
the MTT stock solution were pipetted into each 
well and reduced by viable cells to an insoluble 
formazan product during a further 4 h. After this 
contact period, the medium was removed, and 
the formazan crystals were dissolved in 100 μl 
DMSO by gentle shaking for 60 min. Finally, the 
absorbance was measured at 545 nm with a mi-
croplate reader (Mosmann, 1983). In this way, 
the cell growth or drug toxicity was determined. 
The 50% inhibitory concentration (IC50) was de-
rived from the concentration-response curves fi t-
ted to the measured points by GraphPad Prism 
2.01. All in vitro experiments were carried out 
on 2 microplates with at least 5 parallel wells. 
Cisplatin and doxorubicin were used as positive 
controls.
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